Lund, March 31st, 2020 – Bioextrax AB (publ) has been notified by the European Patent Office (EPO) about an upcoming patent approval for its technology application to extract bioplastics PHA (polyhydroxyalkanoates) from PHA-producing bacteria. The patent will be valid until 2035.

The same bio-based process of extracting bioplastics from PHA-producing microbes has already received ‘Notice of Allowance’ from the US patent authorities.

Bioextrax CEO, Edvard Hall said, “Europe is the most significant market for PHA and the EU patent covers the cost-benefit property that gives us the upper hand over our competition. This is delightful news for the company.”

Download our news release here.

Categories: News